iRhythm Holdings, Inc.
IRTCiRhythm Holdings is a leading digital healthcare company that specializes in remote cardiac monitoring and diagnostic solutions.
Earnings
Next report
Oct 29, 2026 (in a month)Valuation & ratios
Segments
By product
Competitors
By market cap
By revenue growth
By net margin
Profile
iRhythm Holdings is a leading digital healthcare company that specializes in remote cardiac monitoring and diagnostic solutions. The company leverages a proprietary cloud-based data platform and wearable biosensing technology to provide clinical-grade data and analytics for heart rhythm disorders. Their core value proposition centers on improving clinical outcomes and diagnostic yield through long-term continuous monitoring and advanced artificial intelligence.
A leading provider of long-term continuous cardiac monitoring utilizing proprietary AI and wearable biosensor technology.
FAQ
- What is iRhythm Holdings, Inc.'s market cap?
- iRhythm Holdings, Inc. (IRTC) has a market capitalization of $3.7B and trades on NASDAQ.
- What is iRhythm Holdings, Inc.'s revenue and profitability?
- iRhythm Holdings, Inc. generated $825.3M in trailing twelve-month revenue with a net loss of $33.7M, representing a net margin of -7.3%. Gross margin stands at 71.5%, with free cash flow of $39.0M. The latest reported period is Q2 2026.
- Who are iRhythm Holdings, Inc.'s competitors?
- iRhythm Holdings, Inc.'s key competitors include Boston Scientific Corporation, BioTelemetry, Inc., Baxter International Inc., and others. These companies compete in similar markets and product categories.
- Who does iRhythm Holdings, Inc. partner with?
- iRhythm Holdings, Inc.'s notable partners include BioIS.
- Where is iRhythm Holdings, Inc. headquartered?
- iRhythm Holdings, Inc. is headquartered in United States of America and employs approximately 2,000 people. It has been publicly traded since 2016.
